Several possible studies
Story checked
Did Claude discover CRISPR, HHS cuts, GLP-1s: Morning Rounds (opens in a new tab)
statnews.com · 2026-09-28
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Did Claude discover CRISPR, HHS cuts, GLP-1s: Morning Rounds
statnews.com · 2026-09-28
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Cited as backgroundmentioned without context
Global Surgery
Journal of the American College of Surgeons · 2026
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedNovo Nordisk and other companies are reframing GLP-1 drugs from obesity medicines to products marketed as ways to look and feel better generally.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedThe Trump administration clawed back nearly $1 billion in congressionally approved spending, targeting HHS programs focused on immigrants and diversity.View evidenceHide evidence
As statednearly $1 billion
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedAnthropic announced that Claude had found a new enzyme system with DNA repeats that it said was "a pattern reminiscent of CRISPR."View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedAnthropic said it does not yet know the system’s function, so there is still a possibility that it is nothing.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedA research team at OSF Saint Francis Medical Center found that death rates from appendicitis, acute cholecystitis, and abdominal wall hernia with obstruction rose by 50% over 20 years among U.S. adults ages 18 to 64, especially in rural communities.View evidenceHide evidence
As stated50%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref, PubMed, Europe PMC · 16 candidate papers
Global Surgery
Journal of the American College of Surgeons · 2026 · Crossref
Anthropic's AI biolab finds 'CRISPR-like' DNA in viruses. What's next?
Nature · 2026 · PubMed
CRISPR-Cas Genome Editing and Artificial Intelligence for Resilient Crop Disease Control
The Genome Editing Frontier · 2026 · Crossref
Beyond genes: CRISPR/Cas9 for chromosomal engineering in polyploids.
2026 · Europe PMC
New Insights into CRISPR-like Arrays in Helicobacter pylori: An Exploratory Analysis from Genomic Data.
Pathogens (Basel, Switzerland) · 2026 · PubMed
And 11 more candidates considered.